Company page
Crossject Sa
Crossject SA is a public company listed under the ticker ALCJ on the French market. The company has a market capitalization of approximately €129.84 million. Crossject focuses on developing innovative drug delivery systems.
- Ticker
- ALCJ:EURONEXT
- Asset type
- Stock
- Market cap
- $129.8M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- EURONEXT
- Currency
- EUR